about
Premature decline of serum total testosterone in HIV-infected men in the HAART-eraThe burden of image based emphysema and bronchiolitis in HIV-infected individuals on antiretroviral therapyHypertriglyceridemia and waist circumference predict cardiovascular risk among HIV patients: a cross-sectional studyIncidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: data from the Icona Foundation cohort.HCV-HIV coinfected pregnant women: data from a multicentre study in Italy.Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy.Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1.Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV diseaseSeverity of lipodystrophy is associated with decreased health-related quality of life.T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy.HIV-associated lipodystrophy: impact of antiretroviral therapy.Combined use of waist and hip circumference to identify abdominally obese HIV-infected patients at increased health risk.Characterization of specific immune responses to different Aspergillus antigens during the course of invasive Aspergillosis in hematologic patientsAging with HIV vs. HIV seroconversion at older age: a diverse population with distinct comorbidity profiles.Recommendations for evaluation and management of bone disease in HIV.Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.Lung and Heart Diseases Are Better Predicted by Pack-Years than by Smoking Status or Duration of Smoking Cessation in HIV PatientsVitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection.Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfectionFirst Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).Multicenter italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patientsMore than osteoporosis: age-specific issues in bone health.Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.Cost of noninfectious comorbidities in patients with HIV.Evolving perspectives on HIV-associated lipodystrophy syndrome: moving from lipodystrophy to non-infectious HIV co-morbidities.HIV and the body: a review of multidisciplinary management.Male sexual dysfunction and HIV--a clinical perspective.Multimorbidity and functional status assessment.Frailty in people aging with human immunodeficiency virus (HIV) infection.Hypogonadism in the HIV-infected man.Life expectancy in the immune recovery era: the evolving scenario of the HIV epidemic in northern Italy.Antiretroviral treatment in pregnancy: a six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes.Effects of pregnancy on endothelial function and cardiovascular disease risk in HIV-infected women.An Update on Heart Transplantation in Human Immunodeficiency Virus-Infected Patients.Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz.Knowledge, attitudes and practice (KAP) regarding newborn feeding modalities in HIV-infected and HIV-uninfected pregnant women in sub-Saharan Africa: a multicentre study.Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients.
P50
Q28478337-8AB1C705-DB2D-4515-9479-CB2F741F8A74Q28544453-AA2ABB86-0AEE-4BE9-BA30-159CCDCE2870Q28744647-033665F9-C3DB-4B82-A0E7-510E4C25AF0FQ30948574-E49A251B-BBFB-4D5E-ABCE-106E68765949Q31011972-5E7B49E9-8805-45A9-AE17-616822D74B26Q31033395-ABFC58D0-5BD3-4BD3-9BE0-347A3B5E6E9DQ33361817-673F632B-81D4-438B-A42E-A507D0D7FED4Q33971021-754AF41F-1482-4E6F-9A9D-AAD25F15FD06Q34077477-8328A75A-803E-464C-86EE-C1AB81BD9F29Q34087789-48E18A0C-F4D1-4842-9A47-AF6085AF72AAQ34510458-EE44A508-DE79-48FD-BC30-FA902048B017Q34655845-E09AF66A-CBA9-4F6A-B391-0A29B85F41F9Q34734960-08BE6E6B-DCF8-467F-BA95-4E6C71178E02Q34984670-74296ABD-7399-44C0-97C0-41A0497D2390Q35393050-A0DE5E34-81F3-4F01-9167-135046575C5BQ35451868-96F6A8E2-19FF-4CAC-A8E4-8560B14F1944Q35827743-4F0590C9-E031-42F2-9E23-09DA595169EDQ35864381-030AB4BF-B368-4B55-808A-8942A149A076Q36006301-F8781E63-AE8A-4957-B8D8-4983A998EFACQ36467243-FB76CEF6-9C99-4387-860A-2A8CA49D4103Q36848229-AFA49CC7-F480-40F9-B98E-D9B8B8AF311AQ36871711-4CA88F57-62EC-487A-AB4F-CF8A4DDA9416Q36877351-303586AA-202A-4CA5-8177-9BF127B19AE0Q36892885-C4287A4C-BA54-46E1-BF5E-E7376210D88CQ37213494-6EE58D54-C9AC-457A-9B53-F0D73FE2A52BQ37541547-5051CFD9-B7AF-421A-9B7E-0AFB63D0832BQ37798569-B0619A0C-DD4C-465D-95E2-F21FA643441EQ38176192-C84AEB63-AD06-4992-8DC4-C57146E5217EQ38215432-21DC9172-72CC-4ECD-A839-986E19B3AFFCQ38218045-E46870B5-BF41-4887-9CC8-5A810E681F9DQ38244429-EACB6368-CCB8-4CAE-A1C1-9A9024641571Q38422670-3F3C4675-29AE-4C62-AA38-F2BAC07C7111Q38450147-4CD4C4ED-B3B5-435F-AB5C-0B261CE486F0Q38536488-3DFD2B59-437A-4429-969B-BF1FCA4A9A51Q38622238-3AF3350F-02FC-4781-A6F6-B792444099DBQ38669230-60C92B2A-4D67-4B23-8346-079DAF0B461DQ38867641-2F268FAA-ABE2-4F87-9244-4F57E987DF6CQ38870749-AC8C6116-2FCF-4C51-80C0-DFB7EDE12F4AQ38899448-B2B3ECE7-DF13-4EA3-B8C1-7F2A98B95B7CQ38901283-4E65D8F1-B317-425B-9EB9-FFDC7D23EC65
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Giovanni Guaraldi
@ast
Giovanni Guaraldi
@en
Giovanni Guaraldi
@es
Giovanni Guaraldi
@sl
type
label
Giovanni Guaraldi
@ast
Giovanni Guaraldi
@en
Giovanni Guaraldi
@es
Giovanni Guaraldi
@sl
altLabel
Giovanni Guaraldi
@en
prefLabel
Giovanni Guaraldi
@ast
Giovanni Guaraldi
@en
Giovanni Guaraldi
@es
Giovanni Guaraldi
@sl
P106
P1153
35419288400
P21
P31
P496
0000-0002-5724-3914